[Studies on a new hepatotropic contrast medium].
The contrast-material Biliscopin was clinically studied in 101 patients. No side-effects were observed when the injection time was stretched over a 5 min period. The visible heterotopic excretion which correlates with the iodine concentration was low in the case of Biliscopin. Optimal visualisation of the biliary tract was obtained 60--90 min after injection. The remarkably long visualisation of the biliary tract allows tomography beyond 90 min after injection; this is seen as an advantage for X-ray departments with limited tomographic facilities.
D000328:Adult; D000368:Aged; D001660:Biliary Tract Diseases / Q000175:diagnosis*; D003287:Contrast Media / Q000592:standards*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D003287:Contrast Media
Untersuchungen über ein neues hepatotropes Kontrastmittel.